Seed Therapeutics (Seed) Enters Into Strategic Research Collaboration With Eisai Co., Ltd. to Discover and Develop Novel Molecular Glue Degraders for Neurodegeneration and Oncology Indications
Seed Therapeutics（Seed）與Eisai Co.，Ltd.建立戰略性研究合作關係，共同發現和開發治療神經退行性疾病和腫瘤的新型分子粘連降解劑。